Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057

Part of paid clinical trials in Irvine, California.

Sponsor
Masimo Corporation
Study ID
NCT06071754
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Masimo INVSENSOR00057 — DEVICE
    Masimo INVSENSOR00057 will be used to collect electrocardiogram measurements.

Study Details

The objective of this study is to validate the performance of the electrocardiogram (ECG) function of the Masimo INVSENSOR00057 against contemporaneous measurements

Key Dates

Start date
Sep 1, 2023
Status verified
Oct 2025
Primary completion
Apr 30, 2024
Completion
Apr 30, 2024

Study Design

Enrollment
365 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Experimental: INVSENSOR00057
    All subjects are enrolled into this arm and will have ECG measurements obtained

Primary Outcome Measure

Validation of the Performance of the Electrocardiogram (ECG) Function in the Masimo INVSENSOR00057 [ Time Frame: Approximately 30 minutes ]

Locations (4)

FacilityCityStateZIP
Masimo Clinical LabIrvineCalifornia92618
PCA CardiologyLaguna HillsCalifornia92653
Cone HealthGreensboroNorth Carolina27401
Medication ManagementGreensboroNorth Carolina27405

Find similar trials in Irvine, CA

By condition
Atrial fibrillation
By specialty
CardiologyHeart disease
By research site
Masimo Clinical Lab· Irvine, CAPCA Cardiology· Laguna Hills, CACone Health· Greensboro, NCMedication Management· Greensboro, NC

Related Studies